vs
Side-by-side financial comparison of Canaan Inc. (CAN) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.
Canaan Inc. is the larger business by last-quarter revenue ($20.8M vs $17.2M, roughly 1.2× Invivyd, Inc.). Canaan Inc. runs the higher net margin — -18.4% vs -64.3%, a 45.9% gap on every dollar of revenue.
Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
CAN vs IVVD — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $20.8M | $17.2M |
| Net Profit | $-3.8M | $-11.1M |
| Gross Margin | 99.9% | — |
| Operating Margin | -15.9% | -73.0% |
| Net Margin | -18.4% | -64.3% |
| Revenue YoY | — | 24.5% |
| Net Profit YoY | — | 40.0% |
| EPS (diluted) | $-0.05 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.8M | $17.2M | ||
| Q3 25 | $13.8M | $13.1M | ||
| Q2 25 | $11.4M | $11.8M | ||
| Q1 25 | — | $11.3M | ||
| Q4 24 | — | $13.8M | ||
| Q3 24 | $10.2M | $9.3M | ||
| Q2 24 | $4.8M | $2.3M | ||
| Q1 24 | — | $0 |
| Q4 25 | $-3.8M | $-11.1M | ||
| Q3 25 | $-1.5M | $-10.5M | ||
| Q2 25 | $-11.9M | $-14.7M | ||
| Q1 25 | — | $-16.3M | ||
| Q4 24 | — | $-18.4M | ||
| Q3 24 | $-10.4M | $-60.7M | ||
| Q2 24 | $-5.4M | $-47.2M | ||
| Q1 24 | — | $-43.5M |
| Q4 25 | 99.9% | — | ||
| Q3 25 | 99.9% | — | ||
| Q2 25 | 99.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 99.9% | — | ||
| Q2 24 | 99.8% | — | ||
| Q1 24 | — | — |
| Q4 25 | -15.9% | -73.0% | ||
| Q3 25 | -27.0% | -84.0% | ||
| Q2 25 | -45.5% | -127.8% | ||
| Q1 25 | — | -149.7% | ||
| Q4 24 | — | -139.1% | ||
| Q3 24 | -77.2% | -670.0% | ||
| Q2 24 | -193.9% | -2175.2% | ||
| Q1 24 | — | — |
| Q4 25 | -18.4% | -64.3% | ||
| Q3 25 | -11.0% | -79.7% | ||
| Q2 25 | -104.4% | -124.4% | ||
| Q1 25 | — | -144.1% | ||
| Q4 24 | — | -133.5% | ||
| Q3 24 | -102.7% | -653.1% | ||
| Q2 24 | -112.3% | -2086.9% | ||
| Q1 24 | — | — |
| Q4 25 | $-0.05 | $0.02 | ||
| Q3 25 | $-0.02 | $-0.06 | ||
| Q2 25 | $-0.25 | $-0.12 | ||
| Q1 25 | — | $-0.14 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | — | $-0.51 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $226.7M |
| Total DebtLower is stronger | $6.2M | — |
| Stockholders' EquityBook value | $52.4M | $241.5M |
| Total Assets | $92.5M | $276.9M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $226.7M | ||
| Q3 25 | — | $85.0M | ||
| Q2 25 | — | $34.9M | ||
| Q1 25 | — | $48.1M | ||
| Q4 24 | — | $69.3M | ||
| Q3 24 | — | $106.9M | ||
| Q2 24 | — | $147.9M | ||
| Q1 24 | — | $189.4M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $52.4M | $241.5M | ||
| Q3 25 | $44.7M | $93.1M | ||
| Q2 25 | $33.8M | $42.8M | ||
| Q1 25 | — | $54.1M | ||
| Q4 24 | — | $67.5M | ||
| Q3 24 | $43.6M | $83.2M | ||
| Q2 24 | $56.8M | $140.6M | ||
| Q1 24 | — | $178.5M |
| Q4 25 | $92.5M | $276.9M | ||
| Q3 25 | $81.7M | $139.2M | ||
| Q2 25 | $78.0M | $89.1M | ||
| Q1 25 | — | $103.7M | ||
| Q4 24 | — | $129.5M | ||
| Q3 24 | $69.3M | $161.9M | ||
| Q2 24 | $73.7M | $177.3M | ||
| Q1 24 | — | $215.5M |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $-15.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-15.5M | ||
| Q3 25 | — | $-8.3M | ||
| Q2 25 | — | $-13.3M | ||
| Q1 25 | — | $-21.1M | ||
| Q4 24 | — | $-37.6M | ||
| Q3 24 | — | $-41.1M | ||
| Q2 24 | — | $-41.6M | ||
| Q1 24 | — | $-50.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-13.3M | ||
| Q1 25 | — | $-21.3M | ||
| Q4 24 | — | $-37.6M | ||
| Q3 24 | — | $-41.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-50.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -112.9% | ||
| Q1 25 | — | -188.2% | ||
| Q4 24 | — | -272.2% | ||
| Q3 24 | — | -441.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.